stockrow
Friday 6 November 2026
Export MMED’s income statement to Excel — free account
MiniMed Group, Inc.
MMED Healthcare Medical Instruments & Supplies
MiniMed Group, Inc.’s revenue for fiscal 2026 (year ended April 2026) was $3.1 billion, up 14.3% from fiscal 2025.
18.23
1.06
−5.50%
Follow MMED
Alert me
MiniMed Group, Inc. (MMED) Operating margin
MiniMed Group, Inc.'s operating margin over the twelve months to 31 July 2026 was −2.89%, up 3.2 percentage points from fiscal 2026 (−6.13%). That is below the Medical Instruments & Supplies industry median of 1.97% and below the Healthcare sector median of 0.00%.
Operating margin, annual
Embed this chart
Annual newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| FY2026 | −6.13% | (0.79) |
| FY2025 | −5.34% | (2.59) |
| FY2024 | −2.75% | — |
Quarterly newest first
| Period | Operating margin | Change (points) |
|---|---|---|
| Jul 2026 | 0.47% | 13.13 |
| Jan 2026 | −12.7% | (10.72) |
| Jul 2025 | −1.94% | (5.14) |
| Jan 2025 | 3.20% | — |
Operating margin against peers
| Company | Operating margin |
|---|---|
| NVST Envista Holdings Corporation compare | 25.4% |
| STVN Stevanato Group S.p.A. compare | 16.6% |
| MMSI Merit Medical Systems, Inc. compare | 13.5% |
| BLCO Bausch + Lomb Corporation compare | 7.07% |
| ICUI ICU Medical, Inc. compare | 5.07% |
| ATRC AtriCure, Inc. compare | 2.89% |
| TFX Teleflex Incorporated compare | 1.97% |
| MMED MiniMed Group, Inc. | −2.89% |
| PLSE Pulse Biosciences, Inc compare | −5,821.1% |
| Medical Instruments & Supplies industry median | 1.97% |
| Healthcare sector median | 0.00% |
| Market median | 0.00% |
What Operating margin is
EBIT Margin tells an investor how much operating profit, before interest and taxes, a company keeps from each unit of revenue.
EBIT ÷ Revenue
More on MMED
- Revenue
- Net income
- EPS (diluted)
- EBITDA
- Free cash flow
- Operating cash flow
- Gross margin
- Net margin
- Free cash flow margin
- P/E ratio
- P/S ratio
- P/B ratio
- Price to free cash flow
- EV/EBITDA
- EV/Sales
- EV/FCF
- Return on equity
- Return on assets
- Return on invested capital
- Debt to equity
- Shares outstanding
- Book value per share
- The full statement